Saturday 17 October 2026
Export COO’s income statement to Excel — free account
The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
57.94
0.54
+0.94%
Follow COO
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
24.68 | 53.31 | 39.93 | 37.19 |
+8 more quarters Free account |
P/S ratio |
3.29 | 2.90 | 3.80 | 3.40 | |
P/FCF ratio |
20.59 | 21.54 | 32.15 | 32.09 | |
P/Operating CF |
40.85 | 67.10 | 60.53 | 56.15 | |
P/B ratio |
1.68 | 1.49 | 1.89 | 1.69 | |
Price to Tangible BV |
4.64 | 4.29 | 5.41 | 4.97 | |
EV/Sales |
3.86 | 3.45 | 4.38 | 3.99 | |
EV/EBITDA |
17.61 | 16.53 | 16.58 | 15.39 | |
EV/Operating CF |
15.82 | 15.31 | 20.97 | 20.49 | |
EV/FCF |
24.11 | 25.61 | 36.98 | 37.62 | |
Quick Ratio |
0.51 | 0.53 | 0.58 | 0.84 | |
Current Ratio |
1.22 | 1.27 | 1.34 | 1.89 | |
Net Debt/EBITDA |
7.55 | 36.05 | 7.70 | 10.03 | |
Debt/Assets |
20.08% | 19.71% | 20.12% | 20.21% | |
Debt/Equity |
0.31 | 0.30 | 0.30 | 0.30 | |
Asset Turnover |
0.34 | 0.34 | 0.34 | 0.33 | |
Operating CF/Net income |
0.79 | (2.35) | 1.99 | 2.93 | |
Capex/Depreciation |
(0.73) | (0.91) | (1.07) | (1.00) | |
Interest Coverage |
10.33 | (1.48) | 9.50 | 5.75 | |
Research and Development Expense of Revenue |
3.90% | 3.93% | 4.33% | 3.89% | |
Selling, General and Administrative Expense of Revenue |
37.64% | 62.52% | 38.10% | 39.36% | |
Intangible Assets out of Total Assets |
0.42 | 0.43 | 0.44 | 0.44 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.15) | (0.16) | (0.12) | (0.15) | |
Graham Number |
53.34 | 33.49 | 44.06 | 41.84 | |
Earnings Yield |
4.05% | 1.88% | 2.50% | 2.69% | |
Free Cash Flow Yield |
4.86% | 4.64% | 3.11% | 3.12% | |
Revenue per Share |
5.52 | 5.55 | 5.23 | 5.35 | |
Operating CF per Share |
1.77 | 0.94 | 1.33 | 1.25 | |
Capex per Share |
(0.36) | (0.44) | (0.52) | (0.49) | |
Free Cash Flow per Share |
1.41 | 0.49 | 0.81 | 0.75 | |
Cash per Share |
0.80 | 0.71 | 0.64 | 0.56 | |
Shareholders Equity per Share |
43.15 | 42.25 | 42.72 | 41.38 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
43.15 | 42.25 | 42.72 | 41.38 | |
Free Cash Flow |
273.00 | 96.40 | 158.70 | 149.90 | |
Working Capital |
414.90 | 495.10 | 538.10 | 993.60 | |
Capital Expenditures |
(68.70) | (86.40) | (102.20) | (98.00) | |
Net Current Asset Value |
(2,063.50) | (1,943.40) | (1,926.40) | (2,049.30) | |
EV/EBIT |
30.04 | 29.30 | 25.45 | 23.89 | |
Capex to Sales |
0.06 | 0.08 | 0.10 | 0.09 | |
Price to Operating Income |
25.65 | 24.63 | 22.13 | 20.38 | |
| Other line items | |||||
Average Receivables |
790.60 | 795.05 | 761.75 | 773.00 | |
Average Payables |
253.55 | 238.75 | 213.65 | 280.45 | |
Average Inventory |
896.25 | 888.35 | 859.65 | 824.35 | |
Average Assets |
12,525.05 | 12,447.95 | 12,323.20 | 12,355.00 | |
Average Common Equity |
8,340.70 | 8,263.60 | 8,245.75 | 8,161.35 |
Columns are period end dates